These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

425 related articles for article (PubMed ID: 17070032)

  • 1. Has NICE been nice to cancer?
    Summerhayes M; Catchpole P
    Eur J Cancer; 2006 Nov; 42(17):2881-6. PubMed ID: 17070032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Working with NICE.
    Adams C
    J Fam Health Care; 2007; 17(4):113-4. PubMed ID: 17824208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The National Institute for Health and Clinical Excellence and its role in assessing the value of new cancer treatments in England and Wales.
    Trowman R; Chung H; Longson C; Littlejohns P; Clark P
    Clin Cancer Res; 2011 Aug; 17(15):4930-5. PubMed ID: 21791636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the National Institute for Health and Clinical Excellence's technology appraisals on prescribing and net ingredient costs of drugs in the National Health Service in England.
    Dietrich ES
    Int J Technol Assess Health Care; 2009 Jul; 25(3):262-71. PubMed ID: 19619344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How should cost-effectiveness analysis be used in health technology coverage decisions? Evidence from the National Institute for Health and Clinical Excellence approach.
    Williams I; Bryan S; McIver S
    J Health Serv Res Policy; 2007 Apr; 12(2):73-9. PubMed ID: 17407655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reallocating resources: how should the National Institute for Health and Clinical Excellence guide disinvestment efforts in the National Health Service?
    Pearson S; Littlejohns P
    J Health Serv Res Policy; 2007 Jul; 12(3):160-5. PubMed ID: 17716419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Providing guidance to the NHS: The Scottish Medicines Consortium and the National Institute for Clinical Excellence compared.
    Cairns J
    Health Policy; 2006 Apr; 76(2):134-43. PubMed ID: 15982779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NICE's use of cost effectiveness as an exemplar of a deliberative process.
    Culyer AJ
    Health Econ Policy Law; 2006 Jul; 1(Pt 3):299-318. PubMed ID: 18634698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patients' views of explicit rationing: what are the implications for health service decision-making?
    Devlin N; Appleby J; Parkin D
    J Health Serv Res Policy; 2003 Jul; 8(3):183-6. PubMed ID: 12869346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Procedures and methods of benefit assessments for medicines in Germany].
    Bekkering GE; Kleijnen J
    Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Introducing the National Institute for Health and Clinical Excellence.
    Jaques H
    Eur Heart J; 2012 Sep; 33(17):2111-2. PubMed ID: 23106069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of NICE guidance on the uptake of laparoscopic surgery for colorectal cancer.
    Green CJ; Maxwell R; Verne J; Martin RM; Blazeby JM
    J Public Health (Oxf); 2009 Dec; 31(4):541-5. PubMed ID: 19321518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meeting the NICE requirements: a Markov model approach.
    Mauskopf J
    Value Health; 2000; 3(4):287-93. PubMed ID: 16464193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New Medicines in Wales: The All Wales Medicines Strategy Group (AWMSG) Appraisal Process and Outcomes.
    Varnava A; Bracchi R; Samuels K; Hughes DA; Routledge PA
    Pharmacoeconomics; 2018 May; 36(5):613-624. PubMed ID: 29520603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of economic evaluation in local health care decision-making in England: a qualitative investigation.
    Eddama O; Coast J
    Health Policy; 2009 Mar; 89(3):261-70. PubMed ID: 18657336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NHS and charitable funding for children and young people with cancer in England and Wales.
    Linck P; Tunnage B; Hughes DA; Edwards RT
    J Child Health Care; 2008 Jun; 12(2):156-68. PubMed ID: 18469299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current application of National Institute for Health and Clinical Excellence (NICE) guidance in the management of patients with severe psoriasis: a clinical audit against NICE guidance in seven National Health Service specialist dermatology units in England.
    Bewley A; Cerio R; Clement M; Hunt S; Lucke T; Ratnavel R; Walton S; Percival F
    Clin Exp Dermatol; 2011 Aug; 36(6):602-6. PubMed ID: 21392078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence-based medicine, systematic reviews, and guidelines in interventional pain management, part I: introduction and general considerations.
    Manchikanti L
    Pain Physician; 2008; 11(2):161-86. PubMed ID: 18354710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The National Institute for Clinical Excellence and the RCM.
    Palmer L
    RCM Midwives J; 2002 Aug; 5(8):260-1. PubMed ID: 12242758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.